PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds fat hormone's long-sought link to heart protection

A protein called T-cadherin docks the fat hormone adiponectin to the heart, where it guards against stress-induced damage

2010-11-02
(Press-News.org) VIDEO: How adiponectin protects the hearts of healthy people has long been a mystery, and now a team led by Barbara Ranscht, Ph.D. and Pilar Ruiz-Lozano, Ph.D. at Sanford-Burnham Medical Research...
Click here for more information.

LA JOLLA, Calif., November 1, 2010 – One of the many advantages of maintaining a normal body weight is having healthy fat, which in turn supports a healthy heart. Fat tissue is increasingly seen as more than just a storage depot – it's also an active secretory organ that normally produces high levels of a cardioprotective hormone called adiponectin. How adiponectin protects the hearts of healthy people has long been a mystery, and now a team led by Barbara Ranscht, Ph.D. and Pilar Ruiz-Lozano, Ph.D. at Sanford-Burnham Medical Research Institute (Sanford-Burnham) reveals that the protein T-cadherin is the receptor that anchors adiponectin to heart cells. This new study, published November 1 in The Journal of Clinical Investigation, helps answer the longstanding question about how adiponectin prevents stress-induced damage in the heart.

"Whereas healthy people usually have high adiponectin levels circulating in their bodies, obese fat is different from healthy fat. Obese fat produces less adiponectin, reflected in lower levels of adiponectin found in serum," explained Dr. Ranscht, professor in Sanford-Burnham's Tumor Microenvironment Program and senior author of the study. "Many clinical studies correlate low adiponectin levels with an increased risk for heart disease, stroke and other cardiovascular dysfunctions."

Dr. Ranscht's laboratory previously studied T-cadherin for its role in brain development and cancer, and had noted T-cadherin's abundant expression in the heart when discovering this molecule in the early nineties. The best way to determine T-cadherin's role in heart protection is to see what happens when the protein is missing, so Dr. Ranscht and colleagues engineered mice that lacked T-cadherin and looked at their hearts. They found that adiponectin was no longer able to bind to heart tissue, leaving more hormone flowing in the bloodstream. The researchers then exposed T-cadherin-deficient animals to cardiac stress by restricting blood flow. Without the ability to bind adiponectin to the heart, mice with mutant T-cadherin suffered from increased cardiac damage and experienced the same symptoms as mice lacking adiponectin under those conditions.

To further prove T-cadherin's partnership with adiponectin in cardiac protection, the researchers attempted a rescue experiment. It was known that administering adiponectin to adiponectin-deficient mice reverses stress-induced heart damage. If T-cadherin were indeed necessary for mediating adiponectin-induced cardioprotection, then this rescue should not work in T-cadherin-deficient mice. Therefore, the researchers first had to generate a mouse model that lacks both the hormone and the receptor. Indeed, adding adiponectin to the double mutant mice did not rescue the stress-damaged hearts, underscoring the importance of T-cadherin for adiponectin functions in the heart.

How do adiponectin and T-cadherin collaborate to promote healthy hearts? Adiponectin is known to activate a cascade of molecular events converging on a protein called AMP-activated protein kinase (AMPK), which in turn regulates energy usage in the cell. This study showed that T-cadherin is required for adiponectin-induced AMPK activity.

According to Dr. Ranscht, the next steps will be to test if T-cadherin is necessary for adiponectin's other beneficial functions in metabolism and inflammation, and to identify the pathways connecting T-cadherin to AMPK activation in the heart. "Our work shows that T-cadherin is necessary for adiponectin functions, but we still don't know how T-cadherin transmits the adiponectin-binding signal into the cell. We are now searching for proteins that might functionally associate with T-cadherin and thus form the molecular link between T-cadherin and AMPK."

### Martin Denzel, Ph.D., Cecilia Maria Scimia, M.D. and Philine Zumstein, B.S. at Sanford-Burnham and Kenneth Walsh, Ph.D at Boston University co-authored this work. The study was funded by the American Heart Association (AHA) and the National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH). For more information about Sanford-Burnham research, visit http://beaker.sanfordburnham.org.

Original paper

Denzel MS, Scimia M-C, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. The Journal of Clinical Investigation. November 1, 2010.

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country. The Institute ranks among the top independent research institutions nationally for NIH grant funding and among the top organizations worldwide for its research impact. From 1999 – 2009, Sanford-Burnham ranked #1 worldwide among all types of organizations in the fields of biology and biochemistry for the impact of its research publications, defined by citations per publication, according to the Institute for Scientific Information. According to government statistics, Sanford-Burnham ranks #2 nationally among all organizations in capital efficiency of generating patents, defined by the number of patents issued per grant dollars awarded.

Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a nonprofit public benefit corporation. For more information, please visit www.sanfordburnham.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Majority of community facilities performing breast MRI exams meet ACRIN and EUSOBI technical requirements

2010-11-02
An overwhelming majority of Breast Cancer Surveillance Consortium (BCSC) facilities performing breast magnetic resonance imaging (MRI) in the U.S. are up-to-par with American College of Radiology Imaging Network (ACRIN) and European Society of Breast Imaging (EUSOBI) technical standards and requirements, according to a study in the November issue of the Journal of the American College of Radiology (www.jacr.org). The BCSC is a collaborative effort to improve breast cancer research. It consists of five mammography registries and two affiliated sites with linkages to pathology ...

Study of babies' brain scans sheds new light on the brain's unconscious activity and how it develops

2010-11-02
Full-term babies are born with a key collection of networks already formed in their brains, according to new research that challenges some previous theories about the brain's activity and how the brain develops. The study is published today in the journal Proceedings of the National Academy of Sciences. Researchers led by a team from the MRC Clinical Sciences Centre at Imperial College London used functional MRI scanning to look at 'resting state' networks in the brains of 70 babies, born at between 29 and 43 weeks of development, who were receiving treatment at Imperial ...

Arthritis drugs could help prevent memory loss after surgery

2010-11-02
Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive decline after surgery, according to a new study led by researchers at UCSF and colleagues at Imperial College, London. The research explains for the first time why many patients experience memory loss or other forms of cognitive dysfunction after surgery or critical illness, a process the researchers traced to a specific inflammatory response in the brain. The findings could lead directly to human clinical trials in as short as 12 months, the authors ...

Peptide being tested to treat atherosclerosis inhibits ovarian cancer growth

2010-11-02
A drug in testing to treat atherosclerosis significantly inhibited growth of ovarian cancer in both human cell lines and mouse models, the first such report of a peptide being used to fight malignancies, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center. The study follows previous discovery by the same group showing that a protein called apolipoprotein A-I (apoA-I) in patients may be used as a biomarker to diagnose early stage ovarian cancer, when it typically is asymptomatic and is much easier to treat. These earlier findings could be ...

Earth's first great predator wasn't

2010-11-02
Boulder, CO, USA - The meters-long, carnivorous "shrimp" from hell that once ruled the seas of Earth a half billion years ago may have been a real softy, it turns out. A new 3-D modeling of the mouth parts of the Anomalocaris, along with evidence that these parts were not hard like teeth, but flexible, shows that the famed predator could not have been munching on the hard shells of trilobites and other such creatures of the early seas. What's more, there is no evidence from fossilized stomach contents or feces that Anomalocaris' ate anything hard enough to leave a fossilized ...

How lead gets into urban vegetable gardens

2010-11-02
Boulder, CO, USA - One common mitigation approach is to build a raised bed and fill it with freshly composted, low-lead soil from elsewhere, right? Maybe not, according to researchers studying the mysterious case of the lead contamination found within raised beds in community gardens in the Boston communities of Roxbury and Dorchester. "Raised beds are surrounded by a sea of contaminated soil," said Daniel Brabander of Wellesley College. Brabander, his students and colleagues have been studying the lead in 144 backyard gardens in coordination with The Food Project, an ...

Morrison Natural History Museum discovers baby sauropod tracks

Morrison Natural History Museum discovers baby sauropod tracks
2010-11-02
Morrison, CO, USA–Staff at the Morrison Natural History Museum have again discovered infant dinosaur footprints in the foothills west of Denver, Colorado, near the town of Morrison. Dating from the Late Jurassic, some 148 million years ago, these tracks were made before the Rocky Mountains rose, when Morrison was a broad savanna full of dinosaurs. The fossil tracks represent infant sauropods, according to discoverer Matthew Mossbrucker, the museum's director. Sauropods are giant, herbivorous long-necked dinosaurs, sometimes known as "brontosaurs." The sauropod Apatosaurus ...

Scarcity of new energy minerals will trigger trade wars

2010-11-02
Boulder, CO, USA - It's not hard to argue in favor of alternatives to fossil fuels these days, but one popular argument – domestic energy security – may be standing on very shaky legs. A lot of rare metals are needed to make photovoltaic panels, rare earth magnets for wind generators, fuel cells and high-capacity batteries for hybrid and electric vehicles. But most industrialized nations, including the United States, are almost entirely dependent on foreign sources for those metals. The only way this is going to change is if there is more domestic exploration and mining. ...

UC research: Rabbit's food brings luck in decreasing estrogen levels in wastewater

UC research: Rabbits food brings luck in decreasing estrogen levels in wastewater
2010-11-02
The November 2010 issue of "Environmental Pollution" details successful experiments at the University of Cincinnati wherein rabbit's food resulted in the abiotic (non-biological) transformation and absorption of four different types of estrogen, reducing the levels of these estrogen hormones by more than 80 percent in wastewater. The research has practical implications since it could point to inexpensive treatment technologies and materials for reducing estrogens in wastewater. Currently, estrogen in wastewater represents a major conduit for the entry of the hormone, ...

Antibiotics have long-term impacts on gut flora

2010-11-02
Short courses of antibiotics can leave normal gut bacteria harbouring antibiotic resistance genes for up to two years after treatment, say scientists writing in the latest issue of Microbiology, published on 3 November. The researchers believe that this reservoir increases the chances of resistance genes being surrendered to pathogenic bacteria, aiding their survival and suggesting that the long-term effects of antibiotic therapy are more significant than previously thought. Antibiotics that are prescribed to treat pathogenic bacteria also have an impact on the normal ...

LAST 30 PRESS RELEASES:

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

[Press-News.org] Study finds fat hormone's long-sought link to heart protection
A protein called T-cadherin docks the fat hormone adiponectin to the heart, where it guards against stress-induced damage